Balo

Second convening of the Extraordinary Shareholder Meeting on March 8, 2023

Retrieved on: 
Thursday, February 16, 2023
Bulletin, CET, Patient, Proxy, Commercial code, Balo, Security (finance)

Second convening of the Extraordinary Shareholder Meeting on March 8, 2023

Key Points: 
  • Second convening of the Extraordinary Shareholder Meeting on March 8, 2023
    Paris, France, February 16, 2023 – 6.00 pm CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, informs its shareholders that its extraordinary shareholder meeting, convened a second call to vote on the same agenda as the extraordinary shareholder meeting of February 15, 2023.
  • The meeting will be held on Wednesday, March 8, 2023 at 10:30 a.m. at the Company's registered office.
  • The extraordinary shareholder meeting of the Company initially scheduled for February 15, 2023 could not deliberate as it did not obtain the legally required quorum.
  • The agenda and the text of the resolutions of the initial extraordinary shareholder meeting, that was scheduled on February 15, 2023, in the notice that was published in the BALO n°12 of January 27, 2023, remain unchanged.

CGG: Annual Shareholders Meeting on May 12, 2021 First Quarter 2021 Results on May 12, 2021

Retrieved on: 
Tuesday, April 27, 2021
CGG, Euronext, Balo, Companies, Industry economics)

b'Annual Shareholders Meeting on May 12, 2021\nFirst Quarter 2021 Results on May 12, 2021\nCGG announces that a Combined General Meeting (ordinary and extraordinary) will be held on May 12, 2021 at 10.30 a.m. (Paris Time).

Key Points: 
  • b'Annual Shareholders Meeting on May 12, 2021\nFirst Quarter 2021 Results on May 12, 2021\nCGG announces that a Combined General Meeting (ordinary and extraordinary) will be held on May 12, 2021 at 10.30 a.m. (Paris Time).
  • In the context of the health crisis emergency due to the outbreak of Covid-19, the Combined General Meeting of CGG will be held exceptionally behind closed doors, without the physical presence of shareholders, in order to ensure equal access to this Meeting for all and to avoid exposing shareholders to health risks.\nThe preliminary notice of meeting was published on April 5, 2021 in the Bulletin des Annonces L\xc3\xa9gales Obligatoires (BALO).
  • Employing around 3,700 people worldwide, the CGG Group provides a comprehensive range of data, products, services and solutions that support our clients to more efficiently and responsibly solve complex natural resource, environmental and infrastructure challenges.
  • CGG S.A. is listed on the Euronext Paris SA (ISIN: 0013181864).\n'

Sensorion Announces That a General Meeting of Shareholders Will Be Held Behind Closed Doors on May 18, 2021 Alongside the Publication of Its 2020 Annual Financial Report

Retrieved on: 
Friday, April 9, 2021
Biotechnology, Pharmaceutical, Health, Medical devices, Parliamentary procedure, Shareholders, Meetings, Annual general meeting, Mass meeting, Balo

The notice of meeting of the General Meeting was published on April 9, 2021 in the Bulletin des Annonces Lgales Obligatoires (BALO) number 43 (announcement 2100834).

Key Points: 
  • The notice of meeting of the General Meeting was published on April 9, 2021 in the Bulletin des Annonces Lgales Obligatoires (BALO) number 43 (announcement 2100834).
  • Only shareholders having registered their shares at least two business days prior to the date of the general meeting, i.e.
  • midnight, Paris time, on May 14, 2021, will be able to participate in the general meeting.
  • For any questions relating to the Annual General Meeting of May 18, 2021, shareholders are invited to send an email to [email protected] .

ESI Group: Combined General Meeting on 25 June 2020

Retrieved on: 
Tuesday, June 2, 2020
Data management, Engineering, Technology, Manufacturing, Other Technology, Software, Other Manufacturing, Meetings, Shareholders, Pierre André de Suffren, ESI Group, Balo, Annual general meeting

In the context of the Covid-19 pandemic and within the framework of Ordinance n2020-321 of March 25, 2020, ESI Group (Paris:ESI) would like to inform Shareholders that the Combined General Meeting will be exceptionally held behind closed doors, that is without their physical presence, on Thursday 25 June 2020 at 4 p.m. at the head office, 100-102 avenue de Suffren, 75015 Paris, France.

Key Points: 
  • In the context of the Covid-19 pandemic and within the framework of Ordinance n2020-321 of March 25, 2020, ESI Group (Paris:ESI) would like to inform Shareholders that the Combined General Meeting will be exceptionally held behind closed doors, that is without their physical presence, on Thursday 25 June 2020 at 4 p.m. at the head office, 100-102 avenue de Suffren, 75015 Paris, France.
  • The meeting notice, including the agenda and the proposed resolutions to be voted on by Shareholders, was published in the French Bulletin des Annonces Lgales Obligatoires (BALO), on May 6, 2020.
  • The convening notice will be similarly published in the French BALO as well as in a legal gazette on 8 June 2020.
  • Founded in 1973, ESI Group is a leading innovator in Virtual Prototyping solutions and a global enabler of industrial transformation.

Ordinary and Extraordinary General Meeting of April 20, 2020

Retrieved on: 
Monday, March 30, 2020
Meetings, Shareholders, CAC Mid 60, DBV Technologies, Corporate law, DBV, Euronext, MONTROUGE, Balo, Annual general meeting, Extraordinary general meeting, Companies

Ordinary and Extraordinary General Meeting of April 20, 2020

Key Points: 
  • Ordinary and Extraordinary General Meeting of April 20, 2020
    DBV Technologies (Euronext: DBV ISIN: FR0010417345 Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, announced that it will hold its Ordinary and Extraordinary General Meeting on April 20, 2020 at 8:30 a.m. CEST at the Companys headquarters located at 177-181 Avenue Pierre Brossolette 92120 Montrouge, France.
  • The preliminary notice (l'avis pralable) containing the detailed agenda, draft resolutions as well as instructions to participate and vote for this meeting was published in the French Bulletin des Annonces Lgales Obligatoires (BALO) dated March 16, 2020.
  • The notice of meeting (l'avis de convocation) stating the time and place of the meeting will be published in the BALO and in the Legal Gazette on April 3, 2020.
  • DBVs food allergies programs include ongoing clinical trials of Viaskin Peanut and Viaskin Milk, and preclinical development of Viaskin Egg.